| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
3 companies
Canaan IX L.P. last filed a Form 4 in October 2020, as 10% Owner at REAL. The filings on record cover 3 companies.
At the last filing, the largest reported position was 7,925,919 shares of REAL.
Canaan IX L.P. has 25 Form 4 filings on record from October 2015 to October 2020, across 3 companies: 10% Owner at Arvinas (ARVN), 2018–2020; 10% Owner at TheRealReal (REAL), 2019–2020; Director at CytomX Therapeutics (CTMX), 2015–2017.
The 45 reported transactions were 29 open-market sales, 8 other transactions and 8 conversions.
Counted by filing, the open-market trades come to no purchases and 15 sales worth about $6.9M.
The largest open-market sale was 111,498 shares of CTMX at an average $10.01 on June 7, 2016, about $1.1M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 22,086 | $11.18 | $247,007.62 | -0.6% | |
| Nov 28, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 38,459 | $11.56 | $444,404.44 | -1.0% | |
| Nov 22, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 42,550 | $11.71 | $498,077.54 | -1.1% | |
| Nov 21, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 45,324 | $11.61 | $526,087.76 | -1.2% | |
| Nov 16, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 51,581 | $11.50 | $593,428.35 | -1.3% | |
| Nov 14, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 86,270 | $11.16 | $962,906.75 | -2.2% | |
| Nov 9, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 13,730 | $11.03 | $151,498.19 | -0.3% | |
| Jun 10, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 48,427 | $10.07 | $487,498.32 | -1.1% | |
| Jun 7, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 111,498 | $10.01 | $1,116,289.60 | -2.5% | |
| Jun 3, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 59,621 | $10.80 | $644,047.71 | -1.3% |